• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Takeo Usui, Toshiyuki Murai, +7 authors Masayuki Miyasaka
  • Biology, Medicine
  • International immunology
  • 2002 (First Publication: 1 November 2002)
  • Previous results have indicated that mac25/angiomodulin (AGM) is expressed in lymph node (LN) high endothelial venules (HEV), the specialized venules that support efficient lymphocyteExpand
  • Yuri Yamazaki, Koji Tanaka, +19 authors Yoshio Hayashi
  • Medicine, Chemistry
  • Journal of medicinal chemistry
  • 2012 (First Publication: 20 January 2012)
  • Plinabulin (11, NPI-2358) is a potent microtubule-targeting agent derived from the natural diketopiperazine "phenylahistin" (1) with a colchicine-like tubulin depolymerization activity. Compound 11Expand
  • Daisuke Nagakubo, Toshiyuki Murai, +4 authors Masayuki Miyasaka
  • Medicine, Biology
  • The Journal of Immunology
  • 2003 (First Publication: 15 July 2003)
  • We previously reported that mac25/angiomodulin (AGM), a 30-kDa secretory protein, is abundantly expressed in high endothelial venules (HEVs), which play a crucial role in lymphocyte trafficking toExpand
  • Machiko Nakamura, Junko Nakazawa, Takeo Usui, Hiroyuki Osada, Yoshiki Kono, Akira Takatsuki
  • Biology, Medicine
  • Bioscience, biotechnology, and biochemistry
  • 2003 (First Publication: 1 January 2003)
  • Nordihydroguaiaretic acid (NDGA) protected microtubules in NRK cells from depolymerization caused by structurally and functionally diverse drugs such as nocodazole, colchicine, vinblastine, andExpand
  • Yoshiki Hayashi, Haruka Takeno, +8 authors Yoshio Hayashi
  • Chemistry, Medicine
  • ACS medicinal chemistry letters
  • 2014 (First Publication: 28 July 2014)
  • A new benzophenone-diketopiperazine-type potent antimicrotubule agent was developed by modifying the structure of the clinical candidate plinabulin (1). Although the right-hand imidazole ring with aExpand